Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Charite University, Berlin, Germany
In this controlled randomised pilot study the patients are allocated to 1. a ketogenic low glycemic load treatment from the outset of the study for 24 weeks or 2. enhance their regular diet with an initial 7-day fasting followed by a Mediterranean diet pattern until the study end or 3. stay on their regular diet (control group) from the outset of the study for 24 weeks. The investigators will then assess the differences between the groups.
Age
18–68
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Relapsing remitting MS
Stable immunomodulatory treatment or no treatment at least 6 months prior to inclusion
Expanded disability status scale \< 7
Body mass index (BMI) \> or = 18,5 OR BMI \> or = 45 with no risk factors
Not pregnant or breast-feeding
No serious mental health illness such as dementia or schizophrenia;
No use of a weight loss therapy in the month prior to screening.
You may not be if
Start or changes if immunomodulatory treatment \< 7 months prior to screening
SPMS or PPMS
Relapse or corticosteroid use \< 30 days prior to screening
Diabetes or any metabolic defects
Bulimia
Anorexia
Drug abuse
Clareo Health | A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis
